This video is part of a three-part series covering new literature that could influence clinical practice. In this video, I discuss whether beta-blocker use post-MI is beneficial for patients with HFpEF. Background about the mechanism of action and typical place in...
In late 2018, ACC and AHA came out with an update to their cholesterol guidelines. The last update was from 2013 so PCSK-9 inhibitors hadn’t even been approved at that time. Very High Risk Patients – My Biggest Takeaway I always had a hard time knowing...
Study Materials For Pharmacists
Free 18 Page PDF On The Most Notable Drug Interactions!